EIQ.AX is trading 27.4% up at A$1.58 after announcing a strategic A$20 million funding deal and U.S. commercial partnership with Pro Medicus.
- The agreement includes up to A$20 million in secured convertible notes to accelerate the company's growth and commercialization efforts.
- A proposed reseller arrangement will see Pro Medicus offer Echo IQ’s AI cardiology products to its established customer base in the U.S. market.
- Investors view the partnership as a major validation of Echo IQ's technology and a significant catalyst for international expansion.